Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the lopinavir levels in blood of HIV and TB
infected children (3-15kg) when given lopinavir/ritonavir in a 1:1 ratio with rifampicin
containing TB regimen and its safety.
Phase:
Phase 4
Details
Lead Sponsor:
Drugs for Neglected Diseases
Collaborators:
French Development Agency Medecins Sans Frontieres, Netherlands UBS Optimus Foundation University of Cape Town